Insufficient scRNA-seq data for expression of CDC42BPG at single-cell level.
Insufficient scRNA-seq data for expression of CDC42BPG at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
pancreas | 100% | 2412.86 | 327 / 328 | 99% | 21.53 | 176 / 178 |
thymus | 99% | 1981.15 | 644 / 653 | 99% | 34.86 | 600 / 605 |
lung | 97% | 2463.35 | 563 / 578 | 97% | 20.82 | 1116 / 1155 |
prostate | 87% | 2743.19 | 214 / 245 | 99% | 18.76 | 496 / 502 |
stomach | 74% | 2636.18 | 265 / 359 | 95% | 18.08 | 271 / 286 |
kidney | 91% | 1452.48 | 81 / 89 | 75% | 14.53 | 675 / 901 |
breast | 56% | 1682.84 | 257 / 459 | 98% | 21.32 | 1092 / 1118 |
ovary | 47% | 421.22 | 84 / 180 | 95% | 15.52 | 407 / 430 |
intestine | 43% | 1662.28 | 419 / 966 | 97% | 19.30 | 512 / 527 |
bladder | 43% | 1589.24 | 9 / 21 | 95% | 28.73 | 480 / 504 |
esophagus | 38% | 2642.34 | 556 / 1445 | 98% | 33.23 | 180 / 183 |
adrenal gland | 89% | 1373.65 | 229 / 258 | 28% | 5.01 | 64 / 230 |
skin | 72% | 6666.51 | 1305 / 1809 | 30% | 2.68 | 140 / 472 |
tonsil | 0% | 0 | 0 / 0 | 100% | 32.78 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 27.58 | 1 / 1 |
uterus | 5% | 134.75 | 9 / 170 | 91% | 29.92 | 419 / 459 |
eye | 0% | 0 | 0 / 0 | 69% | 5.82 | 55 / 80 |
liver | 1% | 6.56 | 2 / 226 | 26% | 4.09 | 104 / 406 |
spleen | 21% | 177.11 | 50 / 241 | 0% | 0 | 0 / 0 |
brain | 18% | 1571.58 | 467 / 2642 | 1% | 0.08 | 7 / 705 |
lymph node | 0% | 0 | 0 / 0 | 17% | 1.01 | 5 / 29 |
adipose | 2% | 24.55 | 19 / 1204 | 0% | 0 | 0 / 0 |
peripheral blood | 1% | 8.82 | 9 / 929 | 0% | 0 | 0 / 0 |
muscle | 0% | 2.63 | 2 / 803 | 0% | 0 | 0 / 0 |
blood vessel | 0% | 4.67 | 3 / 1335 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
heart | 0% | 0 | 0 / 861 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0018107 | Biological process | peptidyl-threonine phosphorylation |
GO_0030036 | Biological process | actin cytoskeleton organization |
GO_0006468 | Biological process | protein phosphorylation |
GO_0031032 | Biological process | actomyosin structure organization |
GO_0005856 | Cellular component | cytoskeleton |
GO_0005829 | Cellular component | cytosol |
GO_0034451 | Cellular component | centriolar satellite |
GO_0005737 | Cellular component | cytoplasm |
GO_0031252 | Cellular component | cell leading edge |
GO_0005524 | Molecular function | ATP binding |
GO_0004674 | Molecular function | protein serine/threonine kinase activity |
GO_0106310 | Molecular function | protein serine kinase activity |
GO_0005515 | Molecular function | protein binding |
GO_0000287 | Molecular function | magnesium ion binding |
Gene name | CDC42BPG |
Protein name | Serine/threonine-protein kinase MRCK gamma (EC 2.7.11.1) (CDC42-binding protein kinase gamma) (DMPK-like gamma) (Myotonic dystrophy kinase-related CDC42-binding kinase gamma) (MRCK gamma) (MRCKG) (Myotonic dystrophy protein kinase-like gamma) (Myotonic dystrophy protein kinase-like alpha) |
Synonyms | DMPK2 |
Description | FUNCTION: May act as a downstream effector of CDC42 in cytoskeletal reorganization. Contributes to the actomyosin contractility required for cell invasion, through the regulation of MYPT1 and thus MLC2 phosphorylation (By similarity). . |
Accessions | Q6DT37 ENST00000342711.6 |